talipexole has been researched along with bromocriptine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (84.62) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belloni, M; Benarese, M; Memo, M; Pizzi, M; Spano, P | 1 |
| Kulkarni, SK; Verma, A | 1 |
| Fukuda, T; Irifune, M; Nomoto, M | 1 |
| Amano, T; Hongjing, Y; Kohno, Y; Matsubayashi, H; Sasa, M | 1 |
| Fujii, A; Inoue, A; Kohno, Y; Nakata, Y; Negishi, Y; Nishio, H | 1 |
| Fukuzaki, K; Kitahara, K; Kohno, Y; Koja, T | 1 |
| Endo, T; Hamaue, N; Kohno, Y; Minami, M; Nemoto, M | 1 |
| Kitamura, Y; Kohno, Y; Nakazawa, M; Nomura, Y | 1 |
| Kakimura, JI; Kitamura, Y; Kohno, Y; Kosaka, T; Matsuoka, Y; Nomura, Y; Taniguchi, T | 1 |
| Hironaka, N; Kohno, Y; Yanagita, T | 1 |
| Endo, T; Hamaue, N; Hirafuji, M; Ihira, E; Kohno, Y; Minami, M; Nemoto, M; Ogawa, T | 1 |
| Daida, H; Hatano, T; Hattori, N; Iwama, Y; Komine-Kobayashi, M; Mizuno, Y; Mochizuki, H; Nakayama, T; Sakai, M; Urabe, T; Yamashiro, K | 1 |
| Akaike, A; Izumi, Y; Kume, T; Niidome, T; Oda, T; Takada-Takatori, Y | 1 |
13 other study(ies) available for talipexole and bromocriptine
| Article | Year |
|---|---|
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells.
Topics: Adrenergic alpha-Agonists; Animals; Azepines; Bromocriptine; Cells, Cultured; Colforsin; Cyclic AMP; Dopamine Agents; Electric Stimulation; Female; Pituitary Gland, Anterior; Potassium Channels; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 1992 |
Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice.
Topics: Animals; Apomorphine; Azepines; Bromocriptine; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate | 1995 |
Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Azepines; Bromocriptine; Callithrix; Dopamine Agents; Female; Injections, Intravenous; Male; Motor Activity; Parkinson Disease, Secondary; Receptors, Dopamine D2 | 1993 |
Action of intravenously administered talipexole on the rat striatal neurons receiving excitatory input from nigral dopamine neurons.
Topics: Animals; Azepines; Bromocriptine; Corpus Striatum; Dopamine Agonists; Dose-Response Relationship, Drug; Electrophysiology; Injections, Intravenous; Male; Membrane Potentials; Rats; Rats, Wistar; Receptors, Dopamine; Substantia Nigra | 1995 |
5-HT3 receptor blocking properties of the antiparkinsonian agent, talipexole.
Topics: Animals; Azepines; Bromocriptine; Cerebral Cortex; Dopamine Antagonists; Emetics; Female; Guinea Pigs; Heart Atria; Ileum; Imidazoles; In Vitro Techniques; Indoles; Male; Membranes; Muscle Contraction; Muscle, Smooth; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin Antagonists; Tachycardia | 1996 |
Anti-tremor activity of talipexole produced by selective dopamine D2 receptor stimulation in cynomolgus monkeys with unilateral lesions in the ventromedial tegmentum.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Animals; Azepines; Behavior, Animal; Bromocriptine; Dopamine Agents; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Hypnotics and Sedatives; Injections, Subcutaneous; Levodopa; Macaca fascicularis; Male; Receptors, Dopamine D2; Tegmentum Mesencephali; Tremor | 1997 |
Effects of talipexole on emesis-related changes in abdominal afferent vagal activity and ileal serotonin metabolism in rats.
Topics: Abdomen; Animals; Azepines; Biogenic Monoamines; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ileum; Male; Monoamine Oxidase; Rats; Rats, Wistar; Receptors, Dopamine D2; Serotonin; Tryptophan Hydroxylase; Vagus Nerve; Vomiting | 1997 |
Inhibitory effects of talipexole and pramipexole on MPTP-induced dopamine reduction in the striatum of C57BL/6N mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Azepines; Benzothiazoles; Bromocriptine; Dopamine; Dopamine Agents; Dopamine Agonists; Homovanillic Acid; In Vitro Techniques; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neostriatum; Pramipexole; Synaptosomes; Thiazoles | 1997 |
Protective effects of the antiparkinsonian drugs talipexole and pramipexole against 1-methyl-4-phenylpyridinium-induced apoptotic death in human neuroblastoma SH-SY5Y cells.
Topics: 1-Methyl-4-phenylpyridinium; Antiparkinson Agents; Apoptosis; Azepines; Benzothiazoles; Bromocriptine; Bucladesine; Caspase 3; Caspases; Dopamine Agonists; Humans; Pramipexole; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
[Comparative studies on antiparkinsonian agents, talipexole and bromocriptine, evaluated by contralateral rotational behavior in unilaterally nigral-lesioned rats].
Topics: Administration, Oral; Animals; Antiparkinson Agents; Azepines; Behavior, Animal; Benzazepines; Bromocriptine; Dopamine Antagonists; Injections, Subcutaneous; Male; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Substantia Nigra; Sulpiride | 1998 |
Differential effects of talipexole and bromocriptine on serotonin release from rat intestinal tissues--an in vitro study of the emetic response of antiparkinsonian dopamine agonists.
Topics: Administration, Oral; Animals; Azepines; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ileum; Male; Rats; Rats, Wistar; Serotonin | 1999 |
The frequency of cardiac valvular regurgitation in Parkinson's disease.
Topics: Aged; Aortic Valve Insufficiency; Azepines; Benzothiazoles; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Male; Mitral Valve Insufficiency; Parkinson Disease; Pergolide; Pramipexole; Prevalence | 2008 |
Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.
Topics: Animals; Azepines; Benzothiazoles; Blotting, Western; Bromocriptine; Dopamine Agonists; Dose-Response Relationship, Drug; Ergonovine; Ergot Alkaloids; Methylergonovine; Mitogen-Activated Protein Kinases; Neurites; PC12 Cells; Pramipexole; Rats; Receptors, Dopamine D2 | 2008 |